ResMed Inc. (R1MD34)
B3 Stock Exchange · Brazil · prices in BRL · close of 28 Oct 2026
Key indicators
| Last close | BRL 294.47 |
|---|---|
| 52-week range | 238.41 – 357.02 |
| Return, 1 month / 3 months | +20.8% / +21.1% |
| Return, 1 year / 3 years | −15.4% / +59.9% |
| Trend | Uptrend |
| RSI (14) | 100 |
| Volatility (1 year) | 31.0% |
| Worst drawdown (1 year) | -33.8% |
| Average daily value traded | 0.00M BRL |
| Dividend yield | 4.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ResMed Inc. designs and manufactures devices and masks used to treat sleep apnea and other breathing disorders, including positive airway pressure machines and ventilation equipment for use at home and in care settings. It also offers software that helps home medical equipment providers manage patients and equipment. The company is based in San Diego, California, and serves patients, clinicians and healthcare providers in markets around the world.
ResMed Inc. is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code R1MD34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ResMed Inc. (R1MD34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 294.47 on 28 October 2026.
Its price-based Market X-Ray is 46 out of 100 (a weak price profile), ranking 849 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 15.4% and over the last three months it rose 21.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 47 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 7.7% | ||
| From 52-week high | -17.3% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 21.1% | ||
| 6-month return | 6.3% | ||
| 12-month return, skipping the last month | -29.9% | ||
| Stability (higher is calmer) | 58 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.8% | ||
| Liquidity | 6 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M BRL | ||
| Zero-volume days | 98.3% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.1% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +20.8% |
| 3 months | +21.1% |
| 6 months | +6.3% |
| 1 year | −15.4% |
| 3 years | +59.9% |
| 5 years | −13.3% |
Signals
| 50-day / 200-day average | 247.88 / 273.48 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.21 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Aug 2026 | USD 0.6004 |
| 13 May 2026 | USD 0.5393 |
| 11 Feb 2026 | USD 0.5462 |
| 12 Nov 2025 | USD 0.5791 |
| 13 Aug 2025 | USD 0.5593 |
| 7 May 2025 | USD 0.5161 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.